Editors of Blood Select Top 10 Manuscripts from 2017
Studies Include Advancements in Treating Sickle Cell Disease and CAR T-Cell Therapies
Published on: December 22, 2017
(WASHINGTON, December 22, 2017) — This year, there have been more than 1,000 manuscripts published in Blood, the Journal of the American Society of Hematology. To recognize these achievements, Blood Editor-in-Chief Bob Löwenberg, MD, PhD, and Deputy Editor Nancy Berliner, MD, have selected the top 10 most outstanding manuscripts of 2017.
“From major scientific advances and improving therapies in the developing world to harnessing cutting edge technology to conquer blood diseases, 2017 was a remarkable year for hematology,” said Dr. Löwenberg. “Hematology is the frontier for some of the most significant scientific achievements, and we’re honored to highlight some of the top contributions published this year in Blood, the top-cited journal of our field.”
To identify the following top manuscripts of the year, the editors considered quality of the work and interest to the field of hematology. The following articles are listed in no particular order.
Blood (www.bloodjournal.org), the most cited peer-reviewed publication in the field of hematology, is available weekly in print and online. Blood is a journal of the American Society of Hematology (ASH) (www.hematology.org), the world’s largest professional society concerned with the causes and treatment of blood disorders.
ASH’s mission is to further the understanding, diagnosis, treatment, and prevention of disorders affecting blood, bone marrow, and the immunologic, hemostatic, and vascular systems by promoting research, clinical care, education, training, and advocacy in hematology.
blood® is a registered trademark of the American Society of Hematology.
American Society of Hematology
back to top